We are live on ! Find out more
SMH

Sanders Morris Harris Portfolio holdings

AUM $172M
1-Year Est. Return 22.54%
This Fund
S&P 500
This Quarter Est. Return
-20.75%
1 Year Est. Return
+22.54%
3 Year Est. Return
+83.06%
5 Year Est. Return
+84.26%
10 Year Est. Return
+262.54%
AUM
$102M
AUM Growth
-$338M
Cap. Flow
-$103M
Cap. Flow %
-100.58%
Top 10 Hldgs %
36.64%
Holding
305
New
24
Increased
65
Reduced
53
Closed
115

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$10.9M
2
JYNT icon
The Joint Corp
JYNT
+$10.2M
3
AAPL icon
Apple
AAPL
+$8.39M
4
BAC icon
Bank of America
BAC
+$8.09M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$6.93M

Sector Composition

Rank Sector Weight
1 Technology 23.4%
2 Healthcare 18.75%
3 Financials 18.27%
4 Consumer Staples 13.74%
5 Communication Services 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RSG icon
101
Republic Services
RSG
$63.7B
$229K 0.22%
2,550
KLAC icon
102
KLA
KLAC
$252B
$224K 0.22%
17,500
-62,500
-78% -$1.01M
EW icon
103
Edwards Lifesciences
EW
$51.2B
$216K 0.21%
4,020
TDY icon
104
Teledyne Technologies
TDY
$31.7B
$214K 0.21%
600
CACI icon
105
CACI
CACI
$11.4B
$201K 0.2%
1,000
BX icon
106
Blackstone
BX
$109B
$183K 0.18%
364,900
+333,400
+1,058% +$18.4M
NAD icon
107
Nuveen Quality Municipal Income Fund
NAD
$2.74B
$161K 0.16%
16,994
+964
+6% +$13.9K
NRK icon
108
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$901M
$157K 0.15%
17,670
-1,000
-5% -$13.4K
BHC icon
109
Bausch Health
BHC
$2.35B
$147K 0.14%
13,513
-101,587
-88% -$2.45M
CYTK icon
110
Cytokinetics
CYTK
$10.7B
$145K 0.14%
+12,155
New +$155K
MGNX icon
111
MacroGenics
MGNX
$248M
$125K 0.12%
+23,845
New +$217K
NAN icon
112
Nuveen New York Quality Municipal Income Fund
NAN
$368M
$111K 0.11%
10,600
-1,000
-9% -$13.9K
TFFP
113
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$101K 0.1%
756
ET icon
114
Energy Transfer Partners
ET
$70B
$88K 0.09%
202,603
-97,437
-32% -$1.04M
QVCGA
115
DELISTED
QVC Group Inc Series A
QVCGA
$81K 0.08%
206
APTO
116
DELISTED
Aptose Biosciences, Inc.
APTO
$42K 0.04%
25
-487
-95% -$1.45M
PVLA
117
Palvella Therapeutics
PVLA
$2.22B
$41K 0.04%
+243
New +$61.2K
QQQ icon
118
Invesco QQQ Trust
QQQ
$480B
$36K 0.04%
191,063
+63,818
+50% +$13.5M
MO icon
119
Altria Group
MO
$114B
$31K 0.03%
82,156
+4,006
+5% +$178K
JPM icon
120
JPMorgan Chase
JPM
$955B
$24K 0.02%
15,087
-89,702
-86% -$10.9M
KMI icon
121
Kinder Morgan
KMI
$69.3B
$24K 0.02%
55,989
-22,745
-29% -$433K
AR icon
122
Antero Resources
AR
$10.6B
$12K 0.01%
55,000
-27,000
-33% -$45.1K
EPD icon
123
Enterprise Products Partners
EPD
$81.6B
$11K 0.01%
740,757
+187,314
+34% +$4.35M
CSWC icon
124
Capital Southwest
CSWC
$1.52B
$9K 0.01%
821,952
-92,065
-10% -$1.67M
MAIN icon
125
Main Street Capital
MAIN
$5.22B
$7K 0.01%
348,410
-49,524
-12% -$1.85M

Similar funds

Sanders Morris Harris's Q1 2020 Portfolio in Review

As of Q1 2020, Sanders Morris Harris held 305 positions worth $102M, down 77% from $440M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sanders Morris Harris withdrew a net $103M in Q1 2020, closing 115 positions and reducing 53 holdings. Its most notable exit was The Joint Corp, an estimated $10.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Sanders Morris Harris opened a new position in Aimmune Therapeutics worth $5K.

  • Sanders Morris Harris's largest Q1 2020 buy was Aimmune Therapeutics: 341,250 shares worth $5K.
  • Sanders Morris Harris added most to Blackstone in Q1 2020, an estimated $18.4M increase.
  • Sanders Morris Harris's biggest Q1 2020 reduction was JPMorgan Chase, cutting an estimated $10.9M.
  • Sanders Morris Harris fully exited The Joint Corp in Q1 2020, selling an estimated $10.2M.
  • Sanders Morris Harris's ten largest holdings make up 37% of its $102M portfolio in Q1 2020.
  • Sanders Morris Harris opened 24 new positions and closed 115 in Q1 2020.
  • Sanders Morris Harris's portfolio value fell 77% quarter-over-quarter to $102M.

Based on Sanders Morris Harris's 13F filing for Q1 2020, filed 9 Apr 2020.